Skip to content
Subscriber Only

Russian Health Ministry Approves Anti-Coronavirus Drug Avifavir

  • Medicine is a generic version of Japanese flu drug Avigan
  • Russian wealth fund has been conducting trials with ChemRar
Favipiravir Antiviral Manufacture in Russian Direct Investment Fund and ChemRar Joint Venture
Photographer: Andrey Rudakov/Bloomberg

Russia’s Health Ministry granted a temporary registration certificate to the country’s first Covid-19 medicine, a generic version of the Japanese flu drug Avigan, the country’s wealth fund said in statement.

As the coronavirus continues to spread, upending economies and life around the world, drug companies have been racing to develop treatments and vaccines. Avifavir, developed by a joint venture of the Russian Direct Investment Fund and ChemRar Group, is designed to disrupt the novel coronavirus’s ability to reproduce and has proven effective in clinical trials.